ReviewFrontiers in oncology2021

Harnessing DNA Repair Defects to Augment Immune-Based Therapies in Triple-Negative Breast Cancer.

Curtis A Clark et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.